BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31005160)

  • 1. Comparison of diagnostic performance between two prostate imaging reporting and data system versions: A systematic review.
    Li W; Xin C; Zhang L; Dong A; Xu H; Wu Y
    Eur J Radiol; 2019 May; 114():111-119. PubMed ID: 31005160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison of PI-RADS v2 and PI-RADS v1.
    Polanec S; Helbich TH; Bickel H; Pinker-Domenig K; Georg D; Shariat SF; Aulitzky W; Susani M; Baltzer PA
    Eur J Radiol; 2016 Jun; 85(6):1125-31. PubMed ID: 27161062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Diagnostic Performance of PI-RADS V1 and PI-RADS V2 for the Detection of Prostate Cancer: A Meta-Analysis.
    He Y; Cong R; Zhou J; Xu Z; Yang J; Wang L; Xiao J; He B
    Urol J; 2020 Jul; 18(1):51-57. PubMed ID: 32715453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Prostate Imaging Reporting and Data System Version 2.1 for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Park KJ; Choi SH; Kim MH; Kim JK; Jeong IG
    J Magn Reson Imaging; 2021 Jul; 54(1):103-112. PubMed ID: 33576169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer.
    Becker AS; Cornelius A; Reiner CS; Stocker D; Ulbrich EJ; Barth BK; Mortezavi A; Eberli D; Donati OF
    Eur J Radiol; 2017 Sep; 94():58-63. PubMed ID: 28941761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.
    Zhang L; Tang M; Chen S; Lei X; Zhang X; Huan Y
    Eur Radiol; 2017 Dec; 27(12):5204-5214. PubMed ID: 28656462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.
    Hamoen EHJ; de Rooij M; Witjes JA; Barentsz JO; Rovers MM
    Eur Urol; 2015 Jun; 67(6):1112-1121. PubMed ID: 25466942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic value of version 2.1 prostate imaging reporting and data system for prostate transitional zone lesions].
    Yang S; Zhang CY; Zhang YY; Tan SX; Wei CG; Shen XH; Shen JK
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(45):3609-3613. PubMed ID: 33333685
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
    Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
    Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
    AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
    [No Abstract]   [Full Text] [Related]  

  • 15. Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.
    Tewes S; Mokov N; Hartung D; Schick V; Peters I; Schedl P; Pertschy S; Wacker F; Voshage G; Hueper K
    PLoS One; 2016; 11(9):e0162879. PubMed ID: 27657729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
    Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
    Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
    Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.
    Lee CH; Vellayappan B; Tan CH
    Br J Radiol; 2022 Mar; 95(1131):20210509. PubMed ID: 34520694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective Studies.
    Park KJ; Choi SH; Lee JS; Kim JK; Kim MH; Jeong IG
    J Urol; 2020 Dec; 204(6):1141-1149. PubMed ID: 32716687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.
    Auer T; Edlinger M; Bektic J; Nagele U; Herrmann T; Schäfer G; Aigner F; Junker D
    World J Urol; 2017 May; 35(5):687-693. PubMed ID: 27510762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.